Amwill Health Care Quarterly Results for Trading Insights
Latest Quarter Net Profit
₹11 Cr
QMarch 2025
In 2026, Amwill Health Care (AMWILL) reported revenue ₹8 Cr and net profit ₹2 Cr. For annual financials, live price and key ratios, visit AMWILL screener.
AMWILL Quarterly Results — Revenue, Profit & EPS Highlights
Amwill Health Care latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with AMWILL fair price to assess whether the stock is under or overvalued.
- Revenue of ₹41 Cr in March 2025 (+0.0% vs March 2025, -6.8% vs March 2024)
- Net Profit of ₹11 Cr in March 2025 (+0.0% vs March 2025, -15.4% vs March 2024)
- EBITDA of ₹12 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 29.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹6.63 in March 2025 (+0.0% vs March 2025)
Amwill Health Care Quarterly Results — Revenue, EBITDA, Net Profit & EPS
AMWILL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 8 | 41 | 44 | 30 | 28 | -80.5% | - |
| Net Profit (₹ Cr) | 2 | 11 | 13 | 3 | 3 | - | - |
| EBITDA (₹ Cr) | 2 | 12 | 17 | 4 | 4 | - | - |
| EPS (₹) | 299.20 | 6.63 | 8.01 | 2.00 | 1.65 | - | - |
| Operating Margin (%) | 6.0% | 29.0% | 38.0% | 14.0% | 13.0% | - | - |
AMWILL Share Price Trend — 1-Year Movement Across Quarterly Results
Amwill Health Care 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore AMWILL price trends to track price trends across different timeframes.
Revenue Trend (₹ Cr)
March 2023
30
March 2024
44
March 2025
41
2026
8
Net Profit Trend (₹ Cr)
March 2023
3
March 2024
13
March 2025
11
2026
2
Operating Margin Trend (%)
March 2023
14.0%
March 2024
38.0%
March 2025
29.0%
2026
6.0%
AMWILL vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Amwill Health Care latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹450,643.09 Cr | 1878.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 144.5 |
|
Divis Laboratories
Sept 2025 |
₹179,470.03 Cr | 6760.5 | 2,860 | 689 | +7.1% | - | 24.1% | 260.3 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹149,048.00 Cr | 4405.7 | 3,219 | 591 | +11.3% | - | 18.4% | 251.2 |
|
Cipla
Mar 2026 |
₹116,053.85 Cr | 1432.1 | 6,612 | 543 | -14.3% | -4.0% | 8.2% | 208.5 |
|
Dr Reddys Laborator…
Mar 2026 |
₹108,804.06 Cr | 1336.7 | 7,996 | 221 | -12.5% | -11.5% | 2.8% | 504.4 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores